Mineralys Therapeutics Current Cash

Mineralys Therapeutics (MLYS) currently reports a current cash of $110M as of March 2026. That compares with $170M in the prior-year period — down 31.7% year over year. Use the charts on this page to explore Mineralys Therapeutics's current cash history and peer comparisons.

Mineralys Therapeutics's current cash decreased from $170M to $110M — a 31.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mineralys Therapeutics reported $110M in current cash as of March 2026. That compares with $170M in the prior-year period — down 31.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mineralys Therapeutics, and consider following MLYS for alerts when major investors trade the stock.